Are there any new treatments being developed for Parkinson’s disease?

January 18, 2025

The Parkinson’s Protocol™ By Jodi KnappThus, the eBook, The Parkinson’s Protocol, educates you regarding the natural and simple ways to minimize the symptoms and delay the development of Parkinson’s effectively and quickly. It will also help your body to repair itself without following a specific diet plan, using costly ingredients or specific equipment. Its 60 days guarantee to return your money allows you to try for once without any risk.


Are there any new treatments being developed for Parkinson’s disease?

Yes, several new treatments for Parkinson’s disease (PD) have been developed recently, offering hope for improved management of the condition.

FDA Approvals:

  • In August 2024, the FDA approved Crexont, a reformulated, longer-acting levodopa/carbidopa pill, enhancing the management of motor symptoms in PD patients.
  • In October 2024, the FDA approved Vyalev (also known as Produodopa), an injectable treatment for adults with advanced Parkinson’s disease, providing a new option for symptom control in later stages.

Gene Therapy Advancements:

  • Researchers at Michigan State University have developed a novel gene therapy that, in pre-clinical studies, not only reduced or eliminated side effects but also appeared to reverse many Parkinson’s symptoms without medication. This therapy shows potential to halt disease progression.

Adaptive Deep Brain Stimulation:

  • Scientists at the University of California, San Francisco, have developed an adaptive brain pacemaker that can prevent Parkinson’s symptoms before they occur, marking a significant advancement in deep brain stimulation technology.
    Clinical Trials:
  • AbbVie Inc. announced positive results from its third Phase 3 trial of tavapadon, a treatment for early-stage Parkinson’s disease. The trial met its primary and secondary endpoints, and AbbVie plans to seek FDA approval in 2025.

Research Funding:

  • The Michael J. Fox Foundation has granted nearly £5 million to Lario Therapeutics, a Scottish biopharmaceutical company, to support research on CaV2.3 calcium channel inhibition, showing promise as a disease-modifying treatment for Parkinson’s.

These developments reflect a dynamic and hopeful landscape in Parkinson’s disease research and treatment, aiming to improve the quality of life for those affected.

The Parkinson’s Protocol™ By Jodi KnappThus, the eBook, The Parkinson’s Protocol, educates you regarding the natural and simple ways to minimize the symptoms and delay the development of Parkinson’s effectively and quickly. It will also help your body to repair itself without following a specific diet plan, using costly ingredients or specific equipment. Its 60 days guarantee to return your money allows you to try for once without any risk.